Evidence map›Paper›PMID 34716451›Full record

ReviewNature protocols2021

3D bioprinted silk fibroin hydrogels for tissue engineering.

Soon Hee Kim, Heesun Hong, Olatunji Ajiteru, Md Tipu Sultan, Young Jin Lee, Ji Seung Lee, Ok Joo Lee, Hanna Lee, Hae Sang Park, Kyu Young Choi and 4 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Soon Hee Kim *Nano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Heesun Hong *Nano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Olatunji Ajiteru *Nano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.ORCID http://orcid.org/0000-0002-4924-1820
Md Tipu Sultan *Nano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Young Jin LeeNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Ji Seung LeeNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Ok Joo LeeNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Hanna LeeNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Hae Sang ParkNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Kyu Young ChoiNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Joong Seob LeeNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Hyung Woo JuNano-Bio Regenerative Technology Company Ltd., Chuncheon, Republic of Korea.
In-Sun HongDepartment of Molecular Medicine, School of Medicine, Gachon University, Incheon, Republic of Korea.
Chan Hum ParkNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University, Chuncheon, Republic of Korea. hlpch@paran.com.ORCID http://orcid.org/0000-0002-9732-361X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of biocompatible and precisely printable bioink addresses the growing demand for three-dimensional (3D) bioprinting applications in the field of tissue engineering. We developed a methacrylated photocurable silk fibroin (SF) bioink for digital light processing 3D bioprinting to generate structures with high mechanical stability and biocompatibility for tissue engineering applications. Procedure 1 describes the synthesis of photocurable methacrylated SF bioink, which takes 2 weeks to complete. Digital light processing is used to fabricate 3D hydrogels using the bioink (1.5 h), which are characterized in terms of methacrylation, printability, mechanical and rheological properties, and biocompatibility. The physicochemical properties of the bioink can be modulated by varying photopolymerization conditions such as the degree of methacrylation, light intensity, and concentration of the photoinitiator and bioink. The versatile bioink can be used broadly in a range of applications, including nerve tissue engineering through co-polymerization of the bioink with graphene oxide, and for wound healing as a sealant. Procedure 2 outlines how to apply 3D-printed SF hydrogels embedded with chondrocytes and turbinate-derived mesenchymal stem cells in one specific in vivo application, trachea tissue engineering, which takes 2-9 weeks.

Indexed as

AnimalsBioprintingChondrocytesFibroinsGraphiteHumansHydrogelsLightMesenchymal Stem CellsMethacrylatesMiceNerve TissuePrinting, Three-DimensionalRabbitsTissue EngineeringTissue ScaffoldsFibroinsgraphene oxideGraphiteHydrogelsMethacrylates

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.